Song, Mengjia
Pan, Qiuzhong
Yang, Jieying
He, Junyi
Zeng, Jianxiong
Cheng, Shaoyan
Huang, Yue
Zhou, Zi-Qi
Zhu, Qian
Yang, Chaopin
Han, Yulong
Tang, Yan
Chen, Hao
Weng, De-Sheng
Xia, Jian-Chuan http://orcid.org/0000-0002-1268-3967
Article History
Received: 13 February 2020
Revised: 29 June 2020
Accepted: 23 July 2020
First Online: 17 August 2020
Ethics approval and consent to participate
: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Sun Yat-Sen University Cancer Center (Approval No. L102012019010F). Human samples were archived materials obtained with the informed consent of patients. Their use was approved by the Institutional Review Board of Sun Yat-Sen University Cancer Center (Approval No. GZR2017-037). All experiments involving humans were carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki). The human HCC cell lines, HepG2, Hep3B and Sk-Hep1 were acquired from the American Type Culture Collection (Manassas, VA, USA). Huh7 cells were acquired from the Riken Cell Bank (Ibaraki, Japan). Bel-7402 cells were acquired from the Committee of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China).
: All data generated or analysed during this study are included in this published article [and its supplementary information files].
: The authors declare no competing interests.
: This study was funded by the National Key R&D Program of China (grant number 2018YFC1313400, 2018), the National Natural Science Foundation of China (grant number 81773110, 2019), Science and Technology Planning Project of Guangdong Province, China (grant number 2017B020227003, 2017), Science and Technology Planning Project of Guangzhou, Guangdong Province, China (grant number 201704020215, 2017).